摘要
目的:探讨柴芍承气汤联合乌司他丁对重症急性胰腺炎(SAP)及其并发症的临床疗效。方法:64例符合纳入标准的SAP患者按随机数字表格法分为对照组和观察组,各32例。两组患者均给予对症支持的常规治疗,对照组加用乌司他丁;观察组在对照组的基础上加用柴芍承气汤,疗程7天。结果:观察组有效率为96.9%,明显高于对照组的78.1%,差异具有统计学意义(P<0.05);腹痛、胰腺水肿消失时间及首次主动排便时间均明显减少(P<0.05);血尿淀粉酶及白细胞计数恢复时间也明显缩短(P<0.05);并发症与死亡的发生率明显降低(P<0.05)。结论:大承气汤与乌司他丁联用对SAP疗效确切,可降低SAP治疗过程中或治疗后并发症的发生率及死亡率,具有重要临床意义。
Objective: To investigate the clinical efficacy Chaishao Chengqi decoction combined with ulinastatin in the treatment of severe acute pancreatitis( SAP) and its complications. Methods: 64 patients with SAP were randomly divided into a control group and an observation group,32 cases in each group. Patients in two groups were given conventional treatment. The control group was treated with ulinastatin; observation group was on the basis of the control group plus Chaishao Chengqi decoction,with the treatment for 7d. Results: The effective rate was 96. 9% in observation group,significantly higher than 78. 1% in control group,and the difference was statistically significant( P &lt; 0. 05). Abdominal pain,pancreatic edema disappeared and for the first time the initiative defecation was significantly reduced( P &lt; 0. 05); Urine amylase and white blood cell count were significantly shorter recovery time( P &lt; 0. 05); incidence of complications and mortality was significantly lower( P &lt; 0. 05). Conclusion: Chaishao Chengqi decoction combined with ulinastatin has a curative effect on SAP,and the incidence of complications and mortality are reduced and the difference has an important clinical significance.
出处
《中医药信息》
2014年第3期136-138,共3页
Information on Traditional Chinese Medicine
关键词
柴芍承气汤
乌司他丁
急性胰腺炎
并发症
Chaishao Chengqi decoction
Ulinastatin
Acute pancreatitis
Complications